Tag «Janus tyrosine kinase inhibitor»

Milpecitinib

It’s only fair to share… Milpecitinib CAS 1415819-54-3 MF C20H20N4O2S MW380.5 g/mol N-[3-[4-[5-(pyrrolidine-1-carbonyl)-1H-pyrrol-3-yl]-1,3-thiazol-2-yl]phenyl]acetamide N-(3-{4-[5-(pyrrolidine-1-carbonyl)-1H-pyrrol-3-yl]-1,3-thiazol-2-yl}phenyl)acetamideJanus tyrosine kinase inhibitor, anti-inflammatory, veterinary, PF-06263276, PF 06263276, Ph 1012, DNX 04013, CPh 1012, Ph-1012, CVXL 0074-02, 4Q8TT4B4GN Milpecitinib is a small molecule drug. Milpecitinib has a monoisotopic molecular weight of 380.13 Da. Milpecitinib (also known by its developmental codes PF-06263276, Ph-1012, …

Lirucitinib

It’s only fair to share… Lirucitinib CAS 2458115-78-9 MF C16H25N5OS MW335.5 g/mol N-[4-[(ethylsulfonimidoyl)methyl]cyclohexyl]-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (R)-ethyl(imino)({trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methyl)-λ6-sulfanoneJanus tyrosine kinase inhibitor, anti-inflammatory, GGW101, GGW 101 Lirucitinib is a Janus kinase (JAK) inhibitor primarily known as a novel, Class I veterinary drug. It specifically targets the JAK1 enzyme to block itch-inducing (pruritic) and inflammation-causing cytokines in the body. Core Information SYN …